Improving mental health support for children with unusual sensory experiences through a new talking therapy and parent training program

Not Applicable

Conditions: Distressing sensory experiences? (DSE)
Mental and Behavioural Disorders

Registration Number: ISRCTN12245618

Lead Sponsor: Greater Manchester Mental Health NHS Foundation Trust

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Ongoing

Sex: All

Target Recruitment: 120

Inclusion Criteria

Young people and their parent/parent pair (i.e., children and parent/carer dyads) will be eligible if:
1. The child is aged 8-15-years-old and self-identifies as experiencing DSE: due to the current lack of sensitivity of diagnostic or clinical threshold assessments of DSEs, young people who have been referred to CAMHS will automatically be considered eligible for inclusion if they report the presence of DSEs, which will be confirmed by the MAVIC
2. The child is currently under the care of CAMHS
3. At least one parent, primary carer or legal guardian provides consent for trial participation, and in line with Health Research Authority guidance for Research Involving Children, the child provides assent for inclusion into the trial

Exclusion Criteria

Children and parent/carer dyads will be excluded when:
1. Young people unable to engage in conversational English, as the intervention and trial assessments are currently only available in English. If a parent is unable to take part in the PTP, the young person can still engage in the young person’s ChUSE intervention.
2. The child experiences a mental health crisis requiring inpatient hospital admission at the time of study enrolment. The intervention is designed to be accessed as an early intervention on an outpatient basis, so those accessing inpatient CAMHS services will not be eligible for inclusion as they may have urgent clinical needs.
3. The child is already enrolled in another mental health clinical trial involving the provision of an active psychological treatment, as concomitant trial participation may be excessively burdensome and influence outcome assessment.